HEADER TRANSFERASE 24-JAN-07 2E9D TITLE E. COLI UNDECAPRENYL PYROPHOSPHATE SYNTHASE IN COMPLEX WITH BPH-676 COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNDECAPRENYL PYROPHOSPHATE SYNTHETASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: UPP SYNTHETASE, DI-TRANS,POLY-CIS-DECAPRENYLCISTRANSFERASE, COMPND 5 UNDECAPRENYL DIPHOSPHATE SYNTHASE, UDS; COMPND 6 EC: 2.5.1.31; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET32/LIC KEYWDS CELL WALL, PRENYLTRANSFERASE, FARNESYL PYROPHOSPHATE, BISPHOSPHONATE, KEYWDS 2 ANTIBIOTIC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.T.GUO,R.CAO,T.P.KO,P.H.LIANG,E.OLDFIELD,A.H.J.WANG REVDAT 3 25-OCT-23 2E9D 1 REMARK REVDAT 2 17-JUN-08 2E9D 1 JRNL VERSN REVDAT 1 12-JUN-07 2E9D 0 JRNL AUTH R.T.GUO,R.CAO,P.H.LIANG,T.P.KO,T.H.CHANG,M.P.HUDOCK, JRNL AUTH 2 W.Y.JENG,C.K.M.CHEN,Y.ZHANG,Y.SONG,C.J.KUO,F.YIN,E.OLDFIELD, JRNL AUTH 3 A.H.J.WANG JRNL TITL BISPHOSPHONATES TARGET MULTIPLE SITES IN BOTH CIS- AND JRNL TITL 2 TRANS-PRENYLTRANSFERASES JRNL REF PROC.NATL.ACAD.SCI.USA V. 104 10022 2007 JRNL REFN ISSN 0027-8424 JRNL PMID 17535895 JRNL DOI 10.1073/PNAS.0702254104 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 16326 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 809 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.59 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2970 REMARK 3 BIN FREE R VALUE : 0.4030 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 85 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3467 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 206 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2E9D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000026389. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16798 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 7.770 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 41.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 8.18 REMARK 200 R MERGE FOR SHELL (I) : 0.41300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1JP3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% ETHYLENE GLYCOL, 2-5% PEG35K, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.48650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.11700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.14500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.11700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.48650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.14500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET A 2 REMARK 465 LEU A 3 REMARK 465 SER A 4 REMARK 465 ALA A 5 REMARK 465 THR A 6 REMARK 465 GLN A 7 REMARK 465 PRO A 8 REMARK 465 LEU A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 465 LYS A 12 REMARK 465 LEU A 13 REMARK 465 PRO A 14 REMARK 465 ALA A 15 REMARK 465 SER A 72 REMARK 465 GLU A 73 REMARK 465 ASN A 74 REMARK 465 TRP A 75 REMARK 465 ASN A 76 REMARK 465 ARG A 77 REMARK 465 PRO A 78 REMARK 465 ARG A 241 REMARK 465 ARG A 242 REMARK 465 PHE A 243 REMARK 465 GLY A 244 REMARK 465 GLY A 245 REMARK 465 THR A 246 REMARK 465 GLU A 247 REMARK 465 PRO A 248 REMARK 465 GLY A 249 REMARK 465 ASP A 250 REMARK 465 GLU A 251 REMARK 465 THR A 252 REMARK 465 ALA A 253 REMARK 465 MET B 1 REMARK 465 MET B 2 REMARK 465 LEU B 3 REMARK 465 SER B 4 REMARK 465 ALA B 5 REMARK 465 THR B 6 REMARK 465 GLN B 7 REMARK 465 PRO B 8 REMARK 465 LEU B 9 REMARK 465 SER B 10 REMARK 465 GLU B 11 REMARK 465 LYS B 12 REMARK 465 LEU B 13 REMARK 465 PRO B 14 REMARK 465 ALA B 15 REMARK 465 HIS B 16 REMARK 465 GLU B 73 REMARK 465 ASN B 74 REMARK 465 TRP B 75 REMARK 465 ASN B 76 REMARK 465 ARG B 77 REMARK 465 PRO B 78 REMARK 465 ALA B 79 REMARK 465 GLN B 80 REMARK 465 GLU B 81 REMARK 465 VAL B 82 REMARK 465 GLY B 244 REMARK 465 GLY B 245 REMARK 465 THR B 246 REMARK 465 GLU B 247 REMARK 465 PRO B 248 REMARK 465 GLY B 249 REMARK 465 ASP B 250 REMARK 465 GLU B 251 REMARK 465 THR B 252 REMARK 465 ALA B 253 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OAB B76 A 701 O HOH A 486 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 198 CG GLU B 198 CD 0.091 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 204 N - CA - C ANGL. DEV. = -16.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 59 6.59 -59.77 REMARK 500 LEU A 93 26.98 -75.57 REMARK 500 ARG A 123 -14.08 -49.82 REMARK 500 ALA A 132 -36.76 -27.66 REMARK 500 ASP A 170 -4.09 -59.70 REMARK 500 HIS A 199 56.47 -117.27 REMARK 500 PHE A 204 -144.35 -93.29 REMARK 500 GLN B 164 -5.37 -57.38 REMARK 500 HIS B 199 63.64 -117.50 REMARK 500 PHE B 204 -159.89 -87.80 REMARK 500 LEU B 206 -53.69 -120.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B76 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B76 A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B76 B 703 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1X06 RELATED DB: PDB REMARK 900 WILD-TYPE UPPS IN COMPLEX WITH MG, FSPP AND IPP REMARK 900 RELATED ID: 1X07 RELATED DB: PDB REMARK 900 WILD-TYPE UPPS IN COMPLEX WITH MG AND IPP REMARK 900 RELATED ID: 1X08 RELATED DB: PDB REMARK 900 D26A MUTANT UPPS IN COMPLEX WITH MG, FSPP AND IPP REMARK 900 RELATED ID: 1X09 RELATED DB: PDB REMARK 900 D26A MUTANT UPPS IN COMPLEX WITH MG AND IPP REMARK 900 RELATED ID: 2E98 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEX WITH BPH-629 REMARK 900 RELATED ID: 2E99 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEX WITH BPH-608 REMARK 900 RELATED ID: 2E9A RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEX WITH BPH-628 REMARK 900 RELATED ID: 2E9C RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEX WITH BPH-675 DBREF 2E9D A 1 253 UNP P60472 UPPS_ECOLI 1 253 DBREF 2E9D B 1 253 UNP P60472 UPPS_ECOLI 1 253 SEQRES 1 A 253 MET MET LEU SER ALA THR GLN PRO LEU SER GLU LYS LEU SEQRES 2 A 253 PRO ALA HIS GLY CYS ARG HIS VAL ALA ILE ILE MET ASP SEQRES 3 A 253 GLY ASN GLY ARG TRP ALA LYS LYS GLN GLY LYS ILE ARG SEQRES 4 A 253 ALA PHE GLY HIS LYS ALA GLY ALA LYS SER VAL ARG ARG SEQRES 5 A 253 ALA VAL SER PHE ALA ALA ASN ASN GLY ILE GLU ALA LEU SEQRES 6 A 253 THR LEU TYR ALA PHE SER SER GLU ASN TRP ASN ARG PRO SEQRES 7 A 253 ALA GLN GLU VAL SER ALA LEU MET GLU LEU PHE VAL TRP SEQRES 8 A 253 ALA LEU ASP SER GLU VAL LYS SER LEU HIS ARG HIS ASN SEQRES 9 A 253 VAL ARG LEU ARG ILE ILE GLY ASP THR SER ARG PHE ASN SEQRES 10 A 253 SER ARG LEU GLN GLU ARG ILE ARG LYS SER GLU ALA LEU SEQRES 11 A 253 THR ALA GLY ASN THR GLY LEU THR LEU ASN ILE ALA ALA SEQRES 12 A 253 ASN TYR GLY GLY ARG TRP ASP ILE VAL GLN GLY VAL ARG SEQRES 13 A 253 GLN LEU ALA GLU LYS VAL GLN GLN GLY ASN LEU GLN PRO SEQRES 14 A 253 ASP GLN ILE ASP GLU GLU MET LEU ASN GLN HIS VAL CYS SEQRES 15 A 253 MET HIS GLU LEU ALA PRO VAL ASP LEU VAL ILE ARG THR SEQRES 16 A 253 GLY GLY GLU HIS ARG ILE SER ASN PHE LEU LEU TRP GLN SEQRES 17 A 253 ILE ALA TYR ALA GLU LEU TYR PHE THR ASP VAL LEU TRP SEQRES 18 A 253 PRO ASP PHE ASP GLU GLN ASP PHE GLU GLY ALA LEU ASN SEQRES 19 A 253 ALA PHE ALA ASN ARG GLU ARG ARG PHE GLY GLY THR GLU SEQRES 20 A 253 PRO GLY ASP GLU THR ALA SEQRES 1 B 253 MET MET LEU SER ALA THR GLN PRO LEU SER GLU LYS LEU SEQRES 2 B 253 PRO ALA HIS GLY CYS ARG HIS VAL ALA ILE ILE MET ASP SEQRES 3 B 253 GLY ASN GLY ARG TRP ALA LYS LYS GLN GLY LYS ILE ARG SEQRES 4 B 253 ALA PHE GLY HIS LYS ALA GLY ALA LYS SER VAL ARG ARG SEQRES 5 B 253 ALA VAL SER PHE ALA ALA ASN ASN GLY ILE GLU ALA LEU SEQRES 6 B 253 THR LEU TYR ALA PHE SER SER GLU ASN TRP ASN ARG PRO SEQRES 7 B 253 ALA GLN GLU VAL SER ALA LEU MET GLU LEU PHE VAL TRP SEQRES 8 B 253 ALA LEU ASP SER GLU VAL LYS SER LEU HIS ARG HIS ASN SEQRES 9 B 253 VAL ARG LEU ARG ILE ILE GLY ASP THR SER ARG PHE ASN SEQRES 10 B 253 SER ARG LEU GLN GLU ARG ILE ARG LYS SER GLU ALA LEU SEQRES 11 B 253 THR ALA GLY ASN THR GLY LEU THR LEU ASN ILE ALA ALA SEQRES 12 B 253 ASN TYR GLY GLY ARG TRP ASP ILE VAL GLN GLY VAL ARG SEQRES 13 B 253 GLN LEU ALA GLU LYS VAL GLN GLN GLY ASN LEU GLN PRO SEQRES 14 B 253 ASP GLN ILE ASP GLU GLU MET LEU ASN GLN HIS VAL CYS SEQRES 15 B 253 MET HIS GLU LEU ALA PRO VAL ASP LEU VAL ILE ARG THR SEQRES 16 B 253 GLY GLY GLU HIS ARG ILE SER ASN PHE LEU LEU TRP GLN SEQRES 17 B 253 ILE ALA TYR ALA GLU LEU TYR PHE THR ASP VAL LEU TRP SEQRES 18 B 253 PRO ASP PHE ASP GLU GLN ASP PHE GLU GLY ALA LEU ASN SEQRES 19 B 253 ALA PHE ALA ASN ARG GLU ARG ARG PHE GLY GLY THR GLU SEQRES 20 B 253 PRO GLY ASP GLU THR ALA HET B76 A 701 30 HET B76 A 702 30 HET B76 B 703 30 HETNAM B76 [1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1- HETNAM 2 B76 DIYL]BIS(PHOSPHONIC ACID) FORMUL 3 B76 3(C20 H20 O8 P2) FORMUL 6 HOH *206(H2 O) HELIX 1 1 GLY A 27 GLN A 35 1 9 HELIX 2 2 ILE A 38 ASN A 59 1 22 HELIX 3 3 ALA A 79 LEU A 93 1 15 HELIX 4 4 SER A 95 ARG A 102 1 8 HELIX 5 5 ASN A 117 ALA A 132 1 16 HELIX 6 6 GLY A 146 GLY A 165 1 20 HELIX 7 7 GLN A 168 ILE A 172 5 5 HELIX 8 8 ASP A 173 ASN A 178 1 6 HELIX 9 9 GLN A 179 VAL A 181 5 3 HELIX 10 10 LEU A 206 ALA A 210 5 5 HELIX 11 11 LEU A 220 PHE A 224 5 5 HELIX 12 12 ASP A 225 GLU A 240 1 16 HELIX 13 13 GLY B 27 GLN B 35 1 9 HELIX 14 14 ILE B 38 ASN B 60 1 23 HELIX 15 15 SER B 83 HIS B 103 1 21 HELIX 16 16 ASN B 117 ALA B 132 1 16 HELIX 17 17 GLY B 146 GLN B 164 1 19 HELIX 18 18 GLN B 168 ILE B 172 5 5 HELIX 19 19 ASP B 173 GLN B 179 1 7 HELIX 20 20 LEU B 206 ALA B 210 5 5 HELIX 21 21 ASP B 225 PHE B 243 1 19 SHEET 1 A 6 ARG A 106 ARG A 108 0 SHEET 2 A 6 THR A 138 ILE A 141 1 O LEU A 139 N ARG A 108 SHEET 3 A 6 ALA A 64 ALA A 69 1 N LEU A 65 O ASN A 140 SHEET 4 A 6 HIS A 20 MET A 25 1 N MET A 25 O TYR A 68 SHEET 5 A 6 LEU A 191 ARG A 194 1 O ILE A 193 N ALA A 22 SHEET 6 A 6 GLU A 213 PHE A 216 1 O TYR A 215 N VAL A 192 SHEET 1 B 6 ARG B 106 ILE B 110 0 SHEET 2 B 6 THR B 138 ALA B 142 1 O ILE B 141 N ARG B 108 SHEET 3 B 6 ALA B 64 ALA B 69 1 N LEU B 67 O ALA B 142 SHEET 4 B 6 HIS B 20 MET B 25 1 N ILE B 23 O THR B 66 SHEET 5 B 6 LEU B 191 ARG B 194 1 O LEU B 191 N ALA B 22 SHEET 6 B 6 GLU B 213 PHE B 216 1 O TYR B 215 N VAL B 192 SITE 1 AC1 5 ASN A 28 HIS A 43 PHE A 70 SER A 71 SITE 2 AC1 5 HOH A 486 SITE 1 AC2 10 VAL A 50 VAL A 54 SER A 55 ASN A 59 SITE 2 AC2 10 GLU A 96 SER A 99 LEU A 100 HIS A 103 SITE 3 AC2 10 LEU A 139 ILE A 141 SITE 1 AC3 7 VAL B 50 VAL B 54 ASN B 59 GLU B 96 SITE 2 AC3 7 LEU B 100 HIS B 103 HOH B 485 CRYST1 62.973 68.290 110.234 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015880 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014643 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009072 0.00000